Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2281 to 2295 of 8223 results

  1. Camizestrant as an add-on to palbociclib and abemaciclib for untreated hormone receptor-positive HER2-negative metastatic breast cancer with an ESR1 mutation [ID6535]

    In development Reference number: GID-TA11687 Expected publication date: TBC

  2. Infant, children and young people's experience of health care

    Awaiting development Reference number: GID-QS10102 Expected publication date: TBC

  3. Gambling

    Awaiting development Reference number: GID-QS10099 Expected publication date: TBC

  4. Prevention of dementia

    Awaiting development Reference number: GID-QS10109 Expected publication date: TBC

  5. Secondary care management of malignant hypertension

    Awaiting development Reference number: GID-QS10107 Expected publication date: TBC

  6. Sleep disordered breathing

    Awaiting development Reference number: GID-QS10096 Expected publication date: TBC

  7. Readmission to ICU within 48hrs

    Awaiting development Reference number: GID-QS10105 Expected publication date: TBC

  8. Primary hyperparathyroidism

    Awaiting development Reference number: GID-QS10089 Expected publication date: TBC

  9. Radiofrequency ablation of the basivertebral nerve for chronic low back pain

    Topic prioritisation

  10. MRI-guided laser interstitial thermal therapy for early prostate cancer

    Topic prioritisation

  11. High linear energy transfer radiation for carbon ion beam therapy

    Topic prioritisation

  12. Lymphatico-venous anastomosis for chronic lymphoedema

    Topic prioritisation

  13. Oesophageal String Test

    Topic prioritisation

  14. Transcatheter Tricuspid Valve Replacement

    Topic prioritisation

  15. Infrared lasers for treating onychomycosis

    Topic prioritisation